OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?
Robert A. Hauser, William G. Ondo, Yi Zhang, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 403-414
Open Access | Times Cited: 5
Robert A. Hauser, William G. Ondo, Yi Zhang, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 403-414
Open Access | Times Cited: 5
Showing 5 citing articles:
Terminal Care in Parkinson’s Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort
Matthieu Béreau, Mathilde Giffard, Anne-Laure Clairet, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 209-219
Open Access | Times Cited: 5
Matthieu Béreau, Mathilde Giffard, Anne-Laure Clairet, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 209-219
Open Access | Times Cited: 5
Other clinical uses for apomorphine: Sedation and Sleep disorders, Withdrawal of Oral Dopaminergic Medication, Palliative care, Restless Legs Syndrome, Traumatic Brain Injury, Sexual Dysfunction
Pr Marc Vérin, Manon Auffret
Parkinsonism & Related Disorders (2025), pp. 107837-107837
Closed Access
Pr Marc Vérin, Manon Auffret
Parkinsonism & Related Disorders (2025), pp. 107837-107837
Closed Access
Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson’s disease complicated by OFF episodes: a phase 3, open-label study
Jan Kassubek, Stewart A. Factor, Ernest Balaguer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3554-3570
Open Access | Times Cited: 2
Jan Kassubek, Stewart A. Factor, Ernest Balaguer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3554-3570
Open Access | Times Cited: 2
Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson’s Disease: An Open-Label, Randomized, Crossover Study
Fabrizio Stocchi, Olivier Rascol, Werner Poewe, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 8, pp. 1329-1342
Open Access | Times Cited: 4
Fabrizio Stocchi, Olivier Rascol, Werner Poewe, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 8, pp. 1329-1342
Open Access | Times Cited: 4
Sublingual apomorphine in the treatment of Parkinson’s disease
Jan Kassubek, Wolfgang H. Jost, Johannes Schwarz
Journal of Neural Transmission (2024) Vol. 131, Iss. 10, pp. 1209-1216
Closed Access | Times Cited: 1
Jan Kassubek, Wolfgang H. Jost, Johannes Schwarz
Journal of Neural Transmission (2024) Vol. 131, Iss. 10, pp. 1209-1216
Closed Access | Times Cited: 1
